Internal Medicine · Smyrna, TN
NPI
1700846334
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
115 Enon Springs Rd E
Smyrna, TN, 37167
Phone (615) 459-0005
Medicare paid, 2024
$33K
867 services
Medicare patients, 2024
166
Average age 67
Drug cost, 2024
$258K
4,143 prescriptions
Company payments, 2025
$260
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Byrnes was code 99214 (office e&m - established), 216 times for 116 patients. In total John M Byrnes billed 867 services in 35 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 216 | 116 | $65.57 | $14K |
| 99213 Office E&M - Established | Office | 124 | 89 | $38.73 | $4,802 |
| 36415 Venipuncture Blood Collection | Office | 96 | 70 | $8.65 | $830 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 58 | 37 | $23.27 | $1,350 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 56 | 56 | $16.99 | $951 |
| 96372 Injection Administration | Office | 44 | 22 | $8.28 | $364 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 44 | 44 | $118.24 | $5,203 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 31 | 12 | $0.30 | $9.18 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 26 | 18 | $4.24 | $110 |
| 81003 Clinical Chemistry | Office | 18 | 14 | $2.20 | $39.6 |
| 69210 Other Organ Systems | Office | 12 | 12 | $11.97 | $144 |
By year: 2022 $90K for 1,853 services; 2023 $86K for 1,771 services; 2024 $33K for 867 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 96 | 70 | $8.65 | $830 |
| 81003 Clinical Chemistry | 18 | 14 | $2.20 | $39.6 |
Medicare prescription drug claims, 2024
In 2024, the drug John M Byrnes prescribed most often to Medicare patients was Levothyroxine Sodium, with 355 prescriptions and refills. In total John M Byrnes wrote 4,143 Medicare prescriptions that cost $258K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 355 | 452 | 52 | $3,902 |
| Omeprazole Generic | 212 | 255 | 27 | $1,291 |
| Amlodipine Besylate Generic | 170 | 238 | 29 | $473 |
| Simvastatin Generic | 148 | 184 | 22 | $960 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 126 | 126 | 20 | $16K |
| Lisinopril Generic | 110 | 198 | 32 | $528 |
| Famotidine Generic | 107 | 109 | 11 | $1,125 |
| Tamsulosin Hcl Generic | 106 | 140 | 16 | $1,230 |
| Atorvastatin Calcium Generic | 103 | 155 | 28 | $1,271 |
| Rosuvastatin Calcium Generic | 91 | 144 | 22 | $1,032 |
| Metformin Hcl Generic | 73 | 124 | 19 | $411 |
| Lamotrigine Generic | 70 | 85 | Under 11 | $2,577 |
| Furosemide Generic | 58 | 65 | 12 | $240 |
| Topiramate Generic | 52 | 57 | Under 11 | $716 |
| Losartan Potassium Generic | 52 | 73 | Under 11 | $343 |
Brand drugs: 293 claims; generic drugs: 3,837 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Byrnes $260 ($260 in general payments such as food, travel and fees) from 9 companies. The largest payer was Indivior Inc. with $55.88.
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. INDV | 2 | $55.88 |
| Exact Sciences Corporation EXAS | 2 | $42.42 |
| Astellas Pharma US Inc 4503.T | 1 | $33.14 |
| Inspire Medical Systems, Inc. INSP | 1 | $31.24 |
| Novo Nordisk Inc NVO | 1 | $21.1 |
| Antares Pharma, Inc. | 1 | $20.93 |
| Azurity Pharmaceuticals, Inc. | 1 | $19.28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $19.13 |
| Lilly USA, LLC LLY | 1 | $16.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.